Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Innovex International (INVX)

Innovex Q1 revenue falls 4% to $240 million; Q2 guidance sits below Q1 levels

Negative Impact 3 of 5 earnings Written later

Innovex reported first-quarter 2025 revenue of $240 million, down 4% from the prior quarter, with net income of $15 million and Adjusted EBITDA of $46 million. For the second quarter, the company guided to revenue of $225 million to $235 million and Adjusted EBITDA of $40 million to $45 million, both below first-quarter levels, citing softness in Mexico and slight activity declines in the North American land market.

Key points

  • Q1 2025 revenue of $240 million, down 4% quarter over quarter; net income of $15 million; Adjusted EBITDA of $46 million
  • Q2 2025 guidance: total revenue of $225 million to $235 million and Adjusted EBITDA of $40 million to $45 million
  • Agreed to sell the legacy Dril-Quip Eldridge facility for $95 million; the company also has a $100 million share repurchase program
  • As of May 5, 2025, repurchased 395,234 shares at an average price of $14.94

The filing

CompanyInnovex International (INVX)
Form8-K, current report
Filed with the SECMay 6, 2025, 4:31 PM ET
Accession number0000950170-25-064537

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:55 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 06, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.